Muutke küpsiste eelistusi

Josephson School: A Legacy of Important Contributions to Electrophysiology [Kõva köide]

  • Formaat: Hardback, 626 pages, kõrgus x laius x paksus: 279x216x33 mm, kaal: 2260 g
  • Ilmumisaeg: 15-May-2015
  • Kirjastus: Cardiotext Publishing
  • ISBN-10: 1935395343
  • ISBN-13: 9781935395348
Teised raamatud teemal:
  • Formaat: Hardback, 626 pages, kõrgus x laius x paksus: 279x216x33 mm, kaal: 2260 g
  • Ilmumisaeg: 15-May-2015
  • Kirjastus: Cardiotext Publishing
  • ISBN-10: 1935395343
  • ISBN-13: 9781935395348
Teised raamatud teemal:
Contributors xi
Preface and Acknowledgments xvii
The Philadelphia Years xix
Alfred E. Buxton
The Boston Years xxi
Peter Zimetbaum
The European Perspective xxiii
Hein J. Wellens
Following in His Footsteps xxv
Francis E. Marchlinski
The Seventies
Article 1 Mark E. Josephson, MD, Anthony R. Caracta, MD, Sun H. Lau, MD, John J. Gallagher, MD, and Anthony N. Damato, MD. Effects of lidocaine on refractory periods in man. Am Heart J. 1972;84:778--786. Commentary by Martin Borggrefe
3(8)
Article 2 Mark E. Josephson, MD, Stuart E. Seides, MD, William B. Batsford, MD, Anthony R. Caracta, MD, Anthony N. Damato, MD, and John A. Kastor, MD. The effects of carotid sinus pressure in re-entrant paroxysmal supraventricular tachycardia. Am Heart J. 1974;88:694--697. Commentary by John A. Kastor
11(4)
Article 3 Mark E. Josephson, MD, and John A. Kastor, MD. Paroxysmal supraventricular tachycardia: Is the atrium a necessary link? Circulation. 1976;54:430--435. Commentary by Pablo Denes
15(8)
Article 4 Mark E. Josephson, MD, Leonard N. Horowitz, MD, Ardeshir Farshidi, MD, and John A. Kastor, MD. Recurrent sustained ventricular tachycardia.
1. Mechanisms. Circulation. 1978;57:431--440. Commentary by Douglas P. Zipes
23(10)
Article 5 Mark E. Josephson, MD, Leonard N. Horowitz, MD, Ardeshir Farshidi, MD, Joseph F. Spear, PhD, John A. Kastor, MD, and E. Neil Moore, DVM, PhD. Recurrent sustained ventricular tachycardia.
2. Endocardial mapping. Circulation. 1978;57:440--447. Commentary by Hein J. Wellens
33(10)
Article 6 Mark E. Josephson, MD, Leonard N. Horowitz, MD, and Ardeshir Farshidi, MD. Continuous local electrical activity: A mechanism of recurrent ventricular tachycardia. Circulation. 1978;57:659--665. Commentary by Andrew L. Wit
43(12)
Article 7 Scott R. Spielman, MD, Ardeshir Farshidi, MD, FACC, Leonard N. Horowitz, MD, FACC, and Mark E. Josephson, MD, FACC. Ventricular fibrillation during programmed ventricular stimulation: Incidence and clinical implications. Am J Cardiol. 1978;42:913--918. Commentary by Melvin Scheinman
55(10)
Article 8 Mark E. Josephson, MD, FACC, Scott R. Spielman, MD, Allan M. Greenspan, MD, and Leonard N. Horowitz, MD, FACC. Mechanism of ventricular fibrillation in man: Observations based on electrode catheter recordings. Am J Cardiol. 1979;44:623--631. Commentary by Peng-Sheng Chen
65(10)
Article 9 Mark E. Josephson, MD, Alden H. Harken, MD, and Leonard N. Horowitz, MD. Endocardial excision: A new surgical technique for the treatment of recurrent ventricular tachycardia. Circulation. 1979;60:1430--1439. Commentary by Gerard M. Guiraudon
75(14)
The Eighties
Article 10 Mark E. Josephson, MD, Leonard N. Horowitz, MD, Scott R. Spielman, MD, Allan M. Greenspan, MD, Christine VandePol, MD, and Alden H. Harken, MD. Comparison of endocardial catheter mapping with intraoperative mapping of ventricular tachycardia. Circulation. 1980;61:395--404. Commentary by Michael E. Cain
89(10)
Article 11 Leonard N. Horowitz, MD, Alden H. Harken, MD, John A. Kastor, MD, and Mark E. Josephson, MD. Ventricular resection guided by epicardial and endocardial mapping for treatment of recurrent ventricular tachycardia. N Engl J Med. 1980;302:589--593. Commentary by Eugene Downar
99(6)
Article 12 Rita M. Watson, MD, and Mark E. Josephson, MD, FACC. Atrial flutter. I. Electrophysiologic substrates and modes of initiation and termination. Am J Cardiol. 1980;45:732--741. Commentary by Albert L. Waldo
105(12)
Article 13 Leonard N. Horowitz, MD, FACC, Victoria L. Vetter, MD, Alden H. Harken, MD, FACC, and Mark E. Josephson, MD, FACC. Electrophysiologic characteristics of sustained ventricular tachycardia occurring after repair of tetralogy of Fallot. Am J Cardiol. 1980;46:446--452. Commentary by Edward P. Walsh
117(10)
Article 14 Mark E. Josephson, MD, FACC, Leonard N. Horowitz, MD, FACC, Scott R. Spielman, MD, and Allan M. Greenspan, MD. Electrophysiologic and hemodynamic studies in patients resuscitated from cardiac arrest. Am J Cardiol. 1980;46:948--955. Commentary by Hasan Garan
127(10)
Article 15 Leonard N. Horowitz, MD, Allan M. Greenspan, MD, Scott R. Spielman, MD, and Mark E. Josephson, MD. Torsades de pointes: Electrophysiologic studies in patients without transient pharmacologic or metabolic abnormalities. Circulation. 1981;63:1120--1128. Commentary by Alfred E. Buxton
137(10)
Article 16 Mark E. Josephson, MD, Leonard N. Horowitz, MD, Harvey L. Waxman, MD, Michael E. Cain, MD, Scott R. Spielman, MD, Allan M. Greenspan, MD, Francis E. Marchlinski, MD, and Marilyn D. Ezri, MD. Sustained ventricular tachycardia: Role of the 12-lead electrocardiogram in localizing site of origin. Circulation. 1981 ;64:257-272. Commentary by Roderick Tung
147(16)
Article 17 Mark E. Josephson, MD, FACC, Harvey L. Waxman, MD, FACC, Michael E. Cain, MD, Martin J. Gardner, MD, and Alfred E. Buxton, MD. Ventricular activation during ventricular endocardial pacing. II. Role of pace-mapping to localize origin of ventricular tachycardia. Am J Cardiol. 1982;50:11--22. Commentary by Francis E. Marchlinski
163(14)
Article 18 Harvey L. Waxman, MD, Alfred E. Buxton, MD, Laura M. Sadowski, BA, and Mark E. Josephson, MD. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. Circulation. 1983;67:30--37. Commentary by Jeremy N. Ruskin
177(10)
Article 19 John J. Fenoglio, Jr., MD, Tuan Due Pham, PhD, Alden H. Harken, MD, Leonard N. Horowitz, MD, Mark E. Josephson, MD, and Andrew L. Wit, PhD. Recurrent sustained ventricular tachycardia: Structure and ultrastructure of subendocardial regions in which tachycardia originates. Circulation. 1983;68:518--533. Commentary by Jeffrey E. Saffitz
187(18)
Article 20 Alfred E. Buxton, MD, Harvey L. Waxman, MD, Francis E. Marchlinski, MD, Michael B. Simson, MD, Dennis Cassidy, MD, and Mark E. Josephson, MD. Right ventricular tachycardia: Clinical and electrophysiologic characteristics. Circulation. 1983;68:917-927. Commentary by Bruce B. Lerman
205(12)
Article 21 John U. Doherty, MD, Michael G. Kienzle, MD, Harvey L. Waxman, MD, Alfred E. Buxton, MD, Francis E. Marchlinski, MD, and Mark E. Josephson, MD. Programmed ventricular stimulation at a second right ventricular site: An analysis of 100 patients, with special reference to sensitivity, specificity and characteristics of patients with induced ventricular tachycardia. Am J Cardiol. 1983;52:1184--1189. Commentary by Sarah Zaman and Pramesh Kovoor
217(8)
Article 22 Joseph A. Vassallo, MD, Dennis M. Cassidy, MD, Francis E. Marchlinski, MD, Alfred E. Buxton, MD, Harvey L. Waxman, MD, John U. Doherty, MD, and Mark E. Josephson, MD. Endocardial activation of left bundle branch block. Circulation. 1984;69:914-923. Commentary by Michael R. Gold
225(12)
Article 23 Alfred E. Buxton, MD, Harvey L. Waxman, MD, Francis E. Marchlinski, MD, and Mark E. Josephson, MD. Atrial conduction: Effects of extrastimuli with and without atrial dysrhythmias. Am J Cardiol. 1984;54:755-761. Commentary by Gregory Feld
237(10)
Article 24 John U. Doherty, MD, Darlene Pembrook-Rogers, E. Wayne Grogan, MD, Rita A. Falcone, Alfred E. Buxton, MD, Francis E. Marchlinski, MD, Dennis M. Cassidy, MD, Michael G. Kienzle, MD, Jesus M. Almendral, MD, and Mark E. Josephson, MD. Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope. Am J Cardiol. 1985; 55:703--708. Commentary by Brian Olshansky
247(10)
Article 25 John M. Miller, MD, Francis E. Marchlinski, MD, Alden H. Harken, MD, W. Clark Hargrove, MD, and Mark E. Josephson, MD. Subendocardial resection for sustained ventricular tachycardia in the early period after acute myocardial infarction. Am J Cardiol. 1985;55:980--984. Commentary by Pierre Page
257(8)
Article 26 Joseph A. Vassallo, MD, Dennis Cassidy, MD, Michael B. Simson, MD, Alfred E. Buxton, MD, Francis E. Marchlinski, MD, and Mark E. Josephson, MD. Relation of late potentials to site of origin of ventricular tachycardia associated with coronary heart disease. Am J Cardiol. 1985;55:985--989. Commentary by Gunter Breithardt
265(8)
Article 27 John M. Miller, MD, Alden H. Harken, MD, FACC, W Clark Hargrove, MD, Mark E. Josephson, MD, FACC, with the technical assistance of T. Franz Orishimo. Pattern of endocardial activation during sustained ventricular tachycardia. J Am Coll Cardiol. 1985;6:1280--1287. Commentary by Rene Cardinal, Pierre Page, and Reginald Nadeau
273(10)
Article 28 Dennis M. Cassidy, MD, Joseph A. Vassallo, MD, John M. Miller, MD, David S. Poll, MD, Alfred E. Buxton, MD, Francis E. Marchlinski, MD, and Mark E. Josephson, MD. Endocardial catheter mapping in patients in sinus rhythm: Relationship to underlying heart disease and ventricular arrhythmias. Circulation. 1986;73:645--652. Commentary by Fred Morady
283(8)
Article 29 Joseph A. Vassallo, MD, Dennis M. Cassidy, MD, John M. Miller, MD, Alfred E. Buxton, MD, FACC, Francis E. Marchlinski, MD, FACC, and Mark E. Josephson, MD, FACC. Left ventricular endocardial activation during right ventricular pacing: Effect of underlying heart disease. J Am Coll Cardiol. 1986;7:1228--1233. Commentary by Jagmeet P. Singh
291(8)
Article 30 Michael G. Kienzle, MD, John U. Doherty, MD, Dennis Cassidy, MD, Alfred E. Buxton, MD, Francis E. Marchlinski, MD, Harvey L. Waxman, MD, and Mark E. Josephson, MD. Electrophysiologic sequelae of chronic myocardial infarction: Local refractoriness and electrographic characteristics of the left ventricle. Am J Cardiol. 1986;58:63--69. Commentary by William G. Stevenson
299(8)
Article 31 Joseph A. Vassallo, MD, Dennis M. Cassidy, MD, Francis E. Marchlinski, MD, John M. Miller, MD, Alfred E. Buxton, MD, and Mark E. Josephson, MD. Abnormalities of endocardial activation pattern in patients with previous healed myocardial infarction and ventricular tachycardia. Am J Cardiol. 1986; 58:479--484. Commentary by Frank Matthias Bogun
307(8)
Article 32 Jesus M. Almendral, MD, Nicholas J. Stamato, MD, Mark E. Rosenthal, MD, Francis E. Marchlinski, MD, John M. Miller, MD, and Mark E. Josephson, MD. Resetting response patterns during sustained ventricular tachycardia: Relationship to the excitable gap. Circulation. 1986;74:722--730. Commentary by Jeronimo Farre
315(10)
Article 33 W. Clark Hargrove III, MD (by invitation), John M. Miller, MD (by invitation), Joseph A. Vassallo, MD (by invitation), and Mark E. Josephson, MD (by invitation). Improved results in the operative management of ventricular tachycardia related to inferior wall infarction. J Thorac Cardiov Sur. 1986;92:726--732. Commentary by David J. Wilber
325(8)
Article 34 Jesus M. Almendral, MD, Charles D. Gottlieb, MD, Mark E. Rosenthal, MD, Nicholas J. Stamato, MD, Alfred E. Buxton, MD, Francis E. Marchlinski, MD, John M. Miller, MD, and Mark E. Josephson, MD. Entrainment of ventricular tachycardia: Explanation for surface electrocardiographic phenomena by analysis of electrograms recorded within the tachycardia circuit. Circulation. 1988;77:569--680. Commentary by Jesus M. Almendral
333(14)
Article 35 Mark E. Rosenthal, MD, Nicholas J. Stamato, MD, Jesus M. Almendral, MD, Charles D. Gottlieb, MD, and Mark E. Josephson, MD. Resetting of ventricular tachycardia with electrocardiographic fusion: Incidence and significance. Circulation. 1988;77:581--588. Commentary by Henry H. Hsia
347(10)
Article 36 John M. Miller, MD, Francis E. Marchlinski, MD, Alfred E. Buxton, MD, and Mark E. Josephson, MD. Relationship between the 12-lead electrocardiogram during ventricular tachycardia and endocardial site of origin in patients with coronary artery disease. Circulation. 1988;77:759--766. Commentary by Jonathan M. Kalman
357(10)
Article 37 Joseph A. Vassallo, MD, Dennis M. Cassidy, MD, K. Elizabeth Kindwall, MD, Francis E. Marchlinski, MD, and Mark E. Josephson, MD. Nonuniform recovery of excitability in the left ventricle. Circulation. 1988;78:1365--1372. Commentary by Charles Antzelevitch
367(8)
Article 38 Nicholas J. Stamato, MD, Lawrence H. Frame, MD, Mark E. Rosenthal, MD, Jesus M. Almendral, MD, Charles D. Gottlieb, MD, and Mark E. Josephson, MD. Procainamide-induced slowing of ventricular tachycardia with insights from analysis of resetting response patters. Am J Cardiol. 1989;63:1455--1461. Commentary by Peter R. Kowey
375(12)
The Nineties
Article 39 John M. Miller, MD, Mark E. Rosenthal, MD, Charles D. Gottlieb, MD, Joseph A. Vassallo, MD, and Mark E. Josephson, MD, with the technical assistance of T. Franz Orishimo, PE. Usefulness of the Δ HA interval to accurately distinguish atrioventricular nodal reentry from orthodromic septal bypass tract tachycardias. Am J Cardiol. 1991;68:1037--1044. Commentary by Noel G. Boyle
387(10)
Article 40 Mark E. Josephson, MD, and John M. Miller, MD. Atrioventricular nodal reentry: Evidence supporting an intranodal location. Pacing Clin Electrophysiol. 1993;16:599--614. Commentary by Jodie Hurwitz
397(16)
Article 41 David J. Callans, MD, Bruce G. Hook, MD, and Mark E. Josephson, MD. Comparison of resetting and entrainment of uniform sustained ventricular tachycardia: Further insights into the characteristics of the excitable gap. Circulation. 1993;87:1229--1238. Commentary by Elad Anter
413(12)
Article 42 David J. Callans, MD, Bruce G. Hook, MD, Raman L. Mitra, MD, and Mark E. Josephson, MD, FACC. Characterization of return cycle responses predictive of successful pacing-mediated termination of ventricular tachycardia. J Am Coll Cardiol. 1995;25:47--53. Commentary by Kenneth A. Ellenbogen
425(8)
Article 43 John M. Miller, MD, George S. Tyson, MD, W. Clark Hargrove, III, MD, Joseph A. Vassallo, MD, Mark E. Rosenthal, MD, and Mark E. Josephson, MD. Effect of subendocardial resection on sinus rhythm endocardial electrogram abnormalities. Circulation. 1995;91:2385--2391. Commentary by John M. Miller
433(10)
Article 44 Frederic Anselme, MD, Bruce Hook, MD, Kevin Monahan, MD, Joost Frederiks, MD, David Callans, MD, Marco Zardini, MD, Laurence M. Epstein, MD, Joseph Zebede, MD, and Mark E. Josephson, MD. Heterogeneity of retrograde fast-pathway conduction pattern in patients with atrioventricular nodal reentry tachycardia: Observations by simultaneous multisite catheter mapping of Koch's triangle. Circulation. 1996;93:960--968. Commentary by Frederic Anselme
443(12)
Article 45 David J. Callans, MD, FACC, Marco Zardini, MD, Charles D. Gottlieb, MD, FACC, and Mark E. Josephson, MD, FACC. The variable contribution of functional and anatomic barriers in human ventricular tachycardia: An analysis with resetting from two sites. J Am Coll Cardiol. 1996;27:1106--1111. Commentary by David J. Callans
455(6)
Article 46 Panos Papageorgiou, MD, PhD, Kevin Monahan, MD, Noel G. Boyle, MD, Mark J. Seifert, MD, Philippa Beswick, BS, Joseph Zebede, MD, Laurence M. Epstein, MD, and Mark E. Josephson, MD. Site-dependent intra-atrial conduction delay: Relationship to initiation of atrial fibrillation. Circulation. 1996;94:384--389. Commentary by Jeffrey Olgin
461(8)
Article 47 Noel G. Boyle, MD, Frederic Anselme, MD, Kevin Monahan, MD, Panos Papageorgiou, MD, Marco Zardini, MD, Joseph Zebede, MD, and Mark E. Josephson, MD. Origin of junctional rhythm during radiofrequency ablation of atrioventricular nodal reentrant tachycardia in patients without structural heart disease. Am J Cardiol. 1997;80:575--580. Commentary by Eric N. Prystowsky
469(8)
Article 48 David T. Huang, MD, Kevin M. Monahan, MD, Peter Zimetbaum, MD, Panogiotis Papageorgiou, MD, PhD, Laurence M. Epstein, MD, and Mark E. Josephson, MD. Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol. 1998;9:462--469. Commentary by Nadir Saoudi
477(8)
Article 49 Ashraf El-Shalakany, MD, Tomy Hadjis, MD, Panos Papageorgiou, MD, PhD, Kevin Monahan, MD, Laurence Epstein, MD, and Mark E. Josephson, MD. Entrainment/mapping criteria for the prediction of termination of ventricular tachycardia by single radiofrequency lesion in patients with coronary artery disease. Circulation. 1999;99:2283-2289. Commentary by David J. Callans
485(10)
Article 50 Frederic Anselme, MD, Panos Papageorgiou, MD, PhD, Kevin Monahan, MD, Marco Zardini, MD, Noel Boyle, MD, Laurence M. Epstein, MD, and Mark E. Josephson, MD. Presence and significance of the left atrionodal connection during atrioventricular nodal reentrant tachycardia. Am J Cardiol. 1999;83:1530--1536. Commentary by David L. Ross
495(12)
The 21st Century
Article 51 Paul Milliez, MD, Allison W. Richardson, MD, Ogundu Obioha-Ngwu, MD, Peter J. Zimetbaum, MD, FACC, Panos Papageorgiou, MD, FACC, PhD, and Mark E. Josephson, MD, FACC. Variable electrocardiographic characteristics of isthmus-dependent atrial flutter. J Am Coll Cardiol. 2002;40:1125--1132. Commentary by Edward P. Gerstenfeld
507(10)
Article 52 Peter Zimetbaum, MD, and Mark E. Josephson, MD. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med. 2003;348:933--940. Commentary by Peter Zimetbaum
517(8)
Article 53 Peter J. Zimetbaum, MD, Alfred E. Buxton, MD, William Batsford, MD, John D. Fisher, MD, Gail E. Hafley, MS, Kerry L. Lee, PhD, Michael F. O'Toole, MD, Richard L. Page, MD, Matthew Reynolds, MD, and Mark E. Josephson, MD. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation. 2004;110:766--769. Commentary by Alfred E. Buxton
525(6)
Article 54 Alexei Shvilkin, MD, Kalon K.L. Ho, MD, MSc, Michael R. Rosen, MD, and Mark E. Josephson, MD. T-vector direction differentiates postpacing from ischemic T-wave inversion in precordial leads. Circulation. 2005;111:969--974. Commentary by Michael R. Rosen
531(8)
Article 55 Vidal Essebag, Ferdinando Baldessin, Matthew R. Reynolds, Seth McClennen, Jignesh Shah, Kevin F. Kwaku, Peter Zimetbaum, and Mark E. Josephson. Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation. Eur Heart J. 2005;26:2550--2555. Commentary by Sabine Ernst
539(10)
Article 56 Vivek Y. Reddy, MD, Matthew R. Reynolds, MD, Petr Neuzil, MD, PhD, Allison W. Richardson, MD, Milos Taborsky, MD, PhD, Krit Jongnarangsin, MD, Stepan Kralovec, Lucie Sediva, MD, Jeremy N. Ruskin, MD, and Mark E. Josephson, MD. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657--2665. Commentary by Karl-Heinz Kuck
549(10)
Article 57 Roderick Tung, MD, Peter Zimetbaum, MD, and Mark E. Josephson, MD. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1111--1121. Commentary by Matthew R. Reynolds
559(14)
Article 58 Patricia Tung, MD, Susie N. Hong, MD, Raymond H. Chan, MD, Dana C. Peters, PhD, Thomas H. Hauser, MD, Warren J. Manning, MD, and Mark E. Josephson, MD. Aortic injury is common following pulmonary vein isolation. Heart Rhythm. 2013;10:653--658. Commentary by Samuel Levy
573(8)
Article 59 Maheer Gandhavadi, MD, Eduardo B. Sternick, MD, PhD, FHRS, Warren M. Jackman, MD, FACC, FHRS, Hein J.J. Wellens, MD, PhD, FACC, and Mark E. Josephson, MD, FACC. Characterization of the distal insertion of atriofascicular accessory pathways and mechanisms of QRS patterns in atriofascicular antidromic tachycardia. Heart Rhythm. 2013;10:1385--1392. Commentary by George J. Klein
581